Everyday Health on MSN
Can GLP-1 drugs for obesity and diabetes also treat other diseases?
Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...
FDA approval covers ER-positive/HER2-negative metastatic disease with ESR1 mutations after ≥1 endocrine line, with ...
CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women receiving endocrine therapy for hormone receptor (HR)-positive breast cancer or its ...
WASHINGTON—Donald Patrick McDonnell, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer ...
Beyond weight loss, GLP-1s may offer a "two-for-one" benefit by protecting heart health, which is the leading cause of ...
(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) is approaching a watershed moment in its corporate and clinical trajectory. On September 25, 2025, the FDA is expected to announce its decision on the ...
Septerna, Inc. aims to raise $100 million in an IPO to advance its clinical-stage biopharma treatments for endocrine diseases, with SEP-786 in Phase 1 trials. The hypoparathyroidism treatment market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results